Aelis Farma SA (AELIS)

Currency in EUR
1.32
-0.04(-2.94%)
Closed·
AELIS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
AELIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.271.35
52 wk Range
0.6711.80
Key Statistics
Prev. Close
1.32
Open
1.34
Day's Range
1.27-1.35
52 wk Range
0.67-11.8
Volume
47.05K
Average Volume (3m)
59.5K
1-Year Change
-88.62%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AELIS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.00
Upside
+733.33%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Aelis Farma SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Aelis Farma SA Company Profile

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase II clinical trials to treat cognitive deficits observed in down syndrome, as well as other cognitive impairments. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.

Employees
28
Market
France

Compare AELIS to Peers and Sector

Metrics to compare
AELIS
Peers
Sector
Relationship
P/E Ratio
−2.5x−3.1x−0.5x
PEG Ratio
0.060.030.00
Price/Book
1.8x1.5x2.6x
Price / LTM Sales
3.3x4.5x3.3x
Upside (Analyst Target)
-137.7%43.4%
Fair Value Upside
Unlock1.3%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.00
(+733.33% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.28 / --
Revenue / Forecast
1.44M / --
EPS Revisions
Last 90 days

AELIS Income Statement

People Also Watch

60.60
ABVX
-1.14%
2.43
ALCLS
+5.19%
70.46
TEPRF
+3.62%
3.586
VLS
+3.34%
0.0300
ALTD
+0.67%

FAQ

What Stock Exchange Does Aelis Farma Trade On?

Aelis Farma is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Aelis Farma?

The stock symbol for Aelis Farma is "AELIS."

What Is the Aelis Farma Market Cap?

As of today, Aelis Farma market cap is 17.94M.

What Is Aelis Farma's Earnings Per Share (TTM)?

The Aelis Farma EPS (TTM) is -0.55.

From a Technical Analysis Perspective, Is AELIS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Aelis Farma Stock Split?

Aelis Farma has split 0 times.

How Many Employees Does Aelis Farma Have?

Aelis Farma has 28 employees.

What is the current trading status of Aelis Farma (AELIS)?

As of 08 Aug 2025, Aelis Farma (AELIS) is trading at a price of 1.32, with a previous close of 1.32. The stock has fluctuated within a day range of 1.27 to 1.35, while its 52-week range spans from 0.67 to 11.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.